• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, October 31, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Modified One-Layer Vasovasostomy Matches Gold Standard in Vasectomy Reversal

by
October 28, 2026
in Health
Reading Time: 5 mins read
0
Modified One-Layer Vasovasostomy Matches Gold Standard in Vasectomy Reversal

Modified One-Layer Vasovasostomy Matches Gold Standard in Vasectomy Reversal

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Men who want children after a vasectomy may soon have a simpler surgical option. A retrospective study of 62 men, published in Basic and Clinical Andrology, reports that a modified one-layer microsurgical vasovasostomy achieved patency and pregnancy rates comparable to the formal two-layer technique widely regarded as the gold standard, while cutting operative time by more than half an hour. The modified technique took an average of 118.89 minutes per case, compared with 152.52 minutes for the formal two-layer approach, a difference the authors describe as statistically significant.

Vasovasostomy is the surgical reconnection of the vas deferens, the tube that carries sperm from the testis, after it has been cut during a vasectomy. Vasectomy itself remains one of the most common contraceptive methods worldwide, chosen by roughly 6 to 8 percent of couples. Yet circumstances change. According to the study’s introduction, approximately 6 to 10 percent of men who have undergone vasectomy eventually seek reversal, driven by reasons such as remarriage, a desire for additional children, or the loss of a child. In the United States, where around 500,000 vasectomies are performed each year, roughly 6 percent of men ultimately undergo reversal surgery.

The demand is also growing in China, the setting of the new research. Recent changes in the country’s family planning policy have allowed many families to have additional children, producing what the authors describe as a significant increase in requests for vasectomy reversal. For these couples, microsurgical reconstruction offers something assisted reproductive technology cannot: the possibility of natural conception and multiple future pregnancies, at lower cost. Notably, only about 15 percent of men seeking reversal require vasoepididymostomy, a more complex procedure connecting the vas to the epididymis; the majority can be treated with vasovasostomy alone.

Microsurgical vasovasostomy comes in two main forms. The two-layer technique sutures the delicate inner mucosal lining of the vas first, then reinforces the repair with a second layer of seromuscular stitches, providing excellent access to the lumen and a tight, watertight seal. The one-layer technique uses full-thickness sutures that pass through all tissue layers at once, which is simpler and faster but may compromise the seal. Most microsurgeons favor the two-layer approach, and the formal two-layer microdot technique introduced by Goldstein has become the accepted gold standard. Before suturing, the surgeon marks the cut ends of the vas with a microtip pen to guide precise needle placement.

That precision comes at a price. The human vas deferens has an internal diameter of only 300 to 400 micrometers, so placing six to eight sutures in the mucosal layer demands exceptional microsurgical skill. The authors note that this complexity creates a steep learning curve, prolongs operative time, and limits the technique’s broader clinical application. Their modified one-layer method was designed to keep the accuracy of the microdot approach while simplifying the suturing itself.

The modification works as follows. Under a surgical microscope, the surgeon marks six planned needle entry and exit points at the 12, 2, 4, 6, 8, and 10 o’clock positions on both cross-sections of the vas. Six full-thickness 9-0 polypropylene sutures, guided by these microdots, reapproximate both the muscular and mucosal layers in a single pass. Six additional interrupted 9-0 seromuscular sutures are then placed midway between the full-thickness stitches, reinforcing the anastomosis and improving watertightness. By contrast, the formal two-layer technique uses six interrupted 10-0 sutures for the mucosa followed by six interrupted 9-0 sutures for the seromuscular layer. The authors argue that this configuration combines the accurate mucosal alignment of the two-layer method with the reduced suturing complexity of the one-layer approach, while avoiding knots within the muscularis that could provoke tissue reactions, fibrosis, and anastomotic narrowing.

The study included men operated on by a single experienced surgeon between January 2017 and May 2024. All had previously undergone vasectomy, had no sperm in at least two consecutive semen analyses, and had normal hormone levels and testicular ultrasound findings. Men undergoing vasovasostomy for other causes of obstruction, unilateral repair, or repeat reversal were excluded. Of 89 men initially assessed, 62 completed the final cohort: 27 received the formal two-layer repair and 35 the modified one-layer technique. During surgery, the surgeon confirmed patency of the distal vasal end and examined fluid from the proximal end for sperm or sperm fragments before proceeding with the anastomosis.

The outcomes were strikingly similar between the groups. Patency, defined as motile sperm in the ejaculate during follow-up, was achieved in 91.43 percent of the modified one-layer group (32 of 35 men) and 92.59 percent of the formal two-layer group (25 of 27 men), a difference that was not statistically significant. Pregnancy, confirmed by fetal cardiac activity at six to seven weeks of gestation, occurred in 34.29 percent of the one-layer group and 37.04 percent of the two-layer group, again statistically comparable. Postoperative sperm concentration and motility did not differ between the groups, and no complications or postoperative reobstruction were observed in either arm. Follow-up durations were similar, averaging roughly 20 months, and the mean time to patency was about four months in both groups. Patient age, sperm granuloma status, and obstructive interval, which ranged from 2 to 20 years, were also balanced between the groups.

The findings align with earlier evidence. The Vasovasostomy Study Group previously reported no significant differences in patency and pregnancy rates between one-layer and two-layer techniques, and a subsequent meta-analysis and systematic review reached a similar conclusion. The authors also note that robot-assisted vasovasostomy has shown comparable or potentially favorable results in small studies, but its adoption remains constrained by cost, availability, and training requirements, leaving refinement of conventional microsurgery clinically relevant. They suggest that the shorter operative time matters for surgeons as well as patients, because prolonged, highly precise suturing places considerable technical, physical, and psychological demands on the operator. A less steep learning curve, they argue, could help novice microsurgeons adopt the technique and potentially expand access to effective reconstruction.

The study’s limitations temper these conclusions. Its retrospective design and limited sample size may introduce selection bias and restrict generalizability, and the relatively short follow-up precluded a robust assessment of long-term reobstruction. The authors call for large, prospective randomized controlled trials with longer follow-up to validate the results and evaluate durability. They also acknowledge that previous attempts to simplify vasovasostomy, including limited full-thickness suturing combined with biomaterial wrapping, have shortened operative time, but the efficacy and safety of such adjunctive materials remain unproven. For now, the modified one-layer technique stands as a promising, evidence-supported alternative that preserves the microdot principle of precise alignment while making a notoriously demanding operation faster and more teachable, pending confirmation in larger studies.

Subject of Research: A retrospective comparison of modified one-layer versus formal two-layer microsurgical vasovasostomy outcomes in vasectomy reversal

Article Title: Comparison of modified one-layer and formal two-layer microsurgical vasovasostomy for vasectomy reversal

Article References: Wang, J., Wu, J., Li, J., Zhang, W., Li, D., Yan, J., & Jin, X. (2026). Comparison of modified one-layer and formal two-layer microsurgical vasovasostomy for vasectomy reversal. Basic and Clinical Andrology, 36(1), Article 25. https://doi.org/10.1186/s12610-026-00323-3

Image Credits: AI Generated

DOI: 10.1186/s12610-026-00323-3

Keywords: vasectomy reversal, vasovasostomy, microsurgery, male infertility, surgical technique, patency rate, pregnancy rate, operative time, microdot technique, reproductive medicine, urology, Comparison

News Source: Ophelia Keating. (October 28, 2026). Modified One-Layer Vasovasostomy Matches Gold Standard in Vasectomy Reversal. Scienmag.

Tags: comparisonmale infertilitymicrodot techniquemicrosurgeryoperative timepatency ratepregnancy rateReproductive medicinesurgical techniqueurologyvasectomy reversalvasovasostomy
Share12Tweet7Share2ShareShareShare1

Related Posts

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

October 30, 2026
Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

Most Ethiopian HIV patients on dolutegravir therapy show good knowledge, survey finds

October 30, 2026

Serum and urine protein biomarkers may sharpen prostate cancer detection beyond PSA

October 30, 2026

One gene locus flags atrial fibrillation risk after major surgery, UK Biobank study finds

October 30, 2026

POPULAR NEWS

  • Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

    29 shares
    Share 12 Tweet 7
  • Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

    29 shares
    Share 12 Tweet 7
  • ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

    29 shares
    Share 12 Tweet 7
  • Systematic review maps sustainability tensions in offshore wind development

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Microbial Sources and Stress Shape the Hidden Endophytes of an Invasive Plant

Firebreaks Leave Lasting Scars in Grasslands While Wildfire Heals Fast

ZNF207 shields glutamine transporter ASCT2 from degradation to fuel liver cancer growth

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.